Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Neoplasms Brain”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06818331
What this trial is testing

Evaluation of Clinical Efficacy and Safety of Specific Mode Electroacupuncture Stimulation for Paclitaxel Across BBB Delivery in Patients With Postoperative Recurrence of Malignant Glioma: A Single-arm Trial

Who this might be right for
Glioma
The Third Affiliated hospital of Zhejiang Chinese Medical University 20
Testing effectiveness (Phase 2)Ended earlyNCT00436436
What this trial is testing

O(6)-Benzylguanine and Temozolomide in Treating Patients With Glioblastoma Multiforme That Did Not Respond to Previous Temozolomide and Radiation Therapy

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT05490875
What this trial is testing

Carotid Ultrasound to Identify Head and Neck Cancer Survivors With High Cardiovascular Risk After Radiation Therapy

Who this might be right for
Head and Neck CancerCarotid Artery StenosisCardiovascular Complication
Wake Forest University Health Sciences 60
Large-scale testing (Phase 3)Looking for participantsNCT06496971
What this trial is testing

A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients

Who this might be right for
Glioblastoma MultiformeGlioblastomaGlioblastoma Multiforme, Adult+5 more
NaviFUS Corporation 32
Testing effectiveness (Phase 2)Ended earlyNCT00387894
What this trial is testing

Erlotinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Brain Tumors
Michael Prados 6
Not applicableUnknownNCT04021212
What this trial is testing

Pituitary Adenoma and Serum Lipid

Who this might be right for
Pituitary Adenoma 1, Acth-Secreting
Shandong Provincial Hospital 1,000
Testing effectiveness (Phase 2)Looking for participantsNCT07134153
What this trial is testing

Phase I/II Study of Intrathecal/Ommaya T-DXd in HER2-Expressing Breast Cancer With Leptomeningeal/Brain Metastases

Who this might be right for
Breast Cancer
Fudan University 139
Not applicableStudy completedNCT05122000
What this trial is testing

Brain Imaging, Nutrition, and Cognition in Breast Cancer Survivors

Who this might be right for
Breast Cancer
Ohio State University 30
Testing effectiveness (Phase 2)Ended earlyNCT00238277
What this trial is testing

Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15
Testing effectiveness (Phase 2)Study completedNCT00003101
What this trial is testing

Combination Chemotherapy and Bone Marrow Transplantation or Peripheral Stem Cell Transplantation in Treating Patients With Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
Memorial Sloan Kettering Cancer Center 60
Early research (Phase 1)Study completedNCT02658981
What this trial is testing

Anti-LAG-3 Alone & in Combination w/ Nivolumab Treating Patients w/ Recurrent GBM (Anti-CD137 Arm Closed 10/16/18)

Who this might be right for
GlioblastomaGliosarcomaRecurrent Brain Neoplasm
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 63
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Not applicableLooking for participantsNCT06519292
What this trial is testing

Immune Checkpoint Inhibitor Associated Cardiovascular Adverse Events in Patients With Cancer

Who this might be right for
Cardiovascular DiseasesArterial ThrombosisMyocardial Infarction+4 more
Hanneke W. M. van Laarhoven 214
Very early researchStudy completedNCT04895592
What this trial is testing

Radiosurgery Before Surgery for the Treatment of Brain Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the BrainMetastatic Malignant Solid Neoplasm
Emory University 26
Testing effectiveness (Phase 2)Study completedNCT00122044
What this trial is testing

Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects

Who this might be right for
Dystonia
University of Southern California 35
Not applicableLooking for participantsNCT07316101
What this trial is testing

Clinical Trial of an Anti-Fog Drainage Device for Endoscopic Endonasal Sellar Region Tumor Surgery

Who this might be right for
Pituitary AdenomaCraniopharyngioma
West China Hospital 20
Early research (Phase 1)Active Not RecruitingNCT04192981
What this trial is testing

GDC-0084 With Radiation Therapy for People With PIK3CA-Mutated Solid Tumor Brain Metastases or Leptomeningeal Metastases

Who this might be right for
Brain MetastasesLeptomeningeal Metastasis
Memorial Sloan Kettering Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT00014300
What this trial is testing

Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 32
Testing effectiveness (Phase 2)Looking for participantsNCT05673928
What this trial is testing

A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)

Who this might be right for
Metastatic Solid TumorBrain Metastases
M.D. Anderson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00590954
What this trial is testing

Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant Gliomas

Who this might be right for
Malignant GliomasCNSBrain Cancer+1 more
Memorial Sloan Kettering Cancer Center 32
Next Page